Citations

Mayo Clinic

Showing 10 of 108585 citations.

Anesthetic Outcomes of Children With Arthrogryposis Syndromes: No Evidence of Hyperthermia
Gleich, Stephen J. , Tien, Michael , Schroeder, Darrell R. , Hanson, Andrew C. , Flick, Randall P., Nemergut, Michael E. , Schroeder, Darrell

Anesthesia & Analgesia | January 17, 2017 | Volume: 124 | Issue: 3 | Pages: 908-914

10.1213/ane.0000000000001822 | PMID 28099287 Get It

BACKGROUND: Arthrogryposis syndromes are a heterogeneous group of disorders characterized by congenital joint contractures often requiring multiple surgeries during childhood to address skeletal and visceral abnormalities. Previous reports suggest that these children have increased perioperative risk, including hypermetabolic events discrete from malignant hyperthermia, difficult airway management, isolated hyperthermia, and difficult IV line placement. We sought to compare children with arthrogryposis multiplex congenita (AMC) versus the less severe, distal arthrogryposis syndromes (DAS) and to evaluate possible intraoperative hyperthermia of patients with AMC. We hypothesized that children with AMC had a greater incidence of intraoperative hyperthermia and more difficulty with airway management and IV access. METHODS: Children aged 0 to 25 years with arthrogryposis syndromes who underwent anesthesia from 1972 to 2013 were identified. The medical records were reviewed for demographics, arthrogryposis type, and anesthetic complications. AMC subjects were compared with DAS subjects. To evaluate the probability of hyperthermia and hypermetabolic responses of patients with AMC, we performed a post hoc case–control analysis. Patients with AMC were matched in a 1:2 ratio to patients without arthrogryposis to evaluate the primary outcome of maximum intraoperative temperature. RESULTS: Forty-five patients with AMC and 16 patients with DAS underwent 264 and 105 unique anesthetics, respectively. There was no significant difference in intraoperative hyperthermia or hypermetabolic events (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.36–2.47; P = .90). Children with AMC were more likely to have difficult IV access (OR, 7.1; 95% CI, 1.81–27.90; P = .005). Additional evidence suggested that difficult airway management (OR, 4.06; 95% CI, 1.01–16.39; P = .049) and hemodynamic instability (OR, 4.22; 95% CI, 1.03–17.26; P = .045) were more likely in children with AMC. From post hoc case–control analysis, there was no significant difference in the mean maximum intraoperative temperature (estimated difference +0.04°C; 95% CI, −0.14 to +0.22; P = .64) or odds of intraoperative hyperthermia (OR, 1.49; 95% CI, 0.78–2.82; P = .223) for patients with AMC compared with control subjects. CONCLUSIONS: Children with arthrogryposis syndromes present challenges to the anesthesia and surgical teams, including greater neuromuscular disease burden and challenging peripheral IV placement, with additional evidence suggesting difficult airway management and intraoperative hemodynamic instability. Although more definitive studies are warranted, we did not find evidence of increased odds of intraoperative hyperthermia or hypermetabolic responses.
Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder
Dubey, Divyanshu , Pittock, Sean J. , Krecke, Karl N. , Flanagan, Eoin P. , Pittock, S J , Flanagan, E P , Dubey, Divyanshu

JAMA Neurology | January 17, 2017 | Volume: 74 | Issue: 3 | Pages: 359

10.1001/jamaneurol.2016.5441 | PMID 28097302 Get It

Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States
Garrett, Giorgia L., Boscardin, John, Lloyd, Amanda Abramson, Ahmed, Rehana L. , Anthony, Tiffany, Bibee, Kristin , Breithaupt, Andrew, Cannon, Jennifer, Chen, Amy , Cheng, J , Fuxench, Zelma C. Chiesa , Colegio, Oscar R. , Curiel‐Lewandrowski, Clara , Guzzo, Christina A. Del, Disse, Max, Dowd, Margaret , Eilers, Robert, Ortiz, Arisa , Golden, Spring, Graves, Michael S., Griffin, John R., Hopkins, R. Samuel, Huang, Conway C. , Jambusaria, Anokhi, Jennings, Thomas , Khetarpal, Shilpi , Kim, Chang-Hyun , Klintmalm, Göran B. , Konicke, Kathryn, Koyfman, Shlomo A. , Lam, Charlene , Leitenberger, Justin J. , Loh, Tiffany Y. , Lowenstein, Stefan E. , Madankumar, Reshmi, Moreau, Jacqueline F. , Nijhawan, Rajiv I. , Ochoa, Shari A. , Olasz, Edit , Otchere, Elaine , Otley, Clark C. , Oulton, Jeremy, Patel, Parth H., Prabhu, Arpan V. , Pugliano‐Mauro, Melissa , Schmults, Chrysalyne D. , Schram, Sarah E., Shih, Allen F. , Shin, Thuzar M. , Soon, Seaver L. , Stein, Jennifer , Sternhell‐Blackwell, Kara, Taylor, Stan, Vidimos, Allison T. , Wu, Peggy A. , Zajdel, Nicholas, Zelac, Daniel E. , Arron, Sarah T. , Kim, Changhyun, Ochoa, Shari, Otley, Clark, Blanc, Paul David , Boscardin, W. John , Morris, Caroline Rose , Bae, Gordon Hyeonjin , Jambusaria‐Pahlajani, Anokhi , Jiang, Shang I. Brian , Karia, Pritesh S. , Lee, Peter, Patel, Vishal Anil , Soriano, Teresa T. , Srivastava, Divya , Nj, Zajdel

JAMA Dermatology | January 17, 2017 | Volume: 153 | Issue: 3 | Pages: 296

10.1001/jamadermatol.2016.4920 | PMID 28097368 Get It

Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States
Mathur, Amit K. , Steidley, D. Eric , Heilman, Raymond L. , Khurmi, Narjeet , Wasif, Nabil , Etzioni, David A. , Moss, Adyr A. , Heilman, Raymond, Etzioni, David, Chang, Yu‐Hui

Transplantation Direct | January 17, 2017 | Volume: 3 | Issue: 2 | Pages: e126

10.1097/txd.0000000000000640 | PMID 28361110 Get It

Background Cardiovascular disease (CVD) is an important driver of mortality after kidney transplantation. Its broader impact on posttransplant health care utilization in US hospitals is unknown. Methods We used administrative claims data from the Nationwide Inpatient Sample and the American Hospital Association Annual Survey to identify hospitalizations for kidney transplant patients with a cardiovascular diagnosis from 2005 to 2011. CVD hospitalizations were stratified by transplant hospital status to characterize patterns in inpatient health care utilization and outcomes. Based on these analyses, the domestic burden of treatment for posttransplant CVD (myocardial infarction, stroke, congestive heart failure, dysrhythmia, cardiac arrest, malignant hypertension) was estimated. Results The total domestic burden of post-kidney transplant hospitalization between 2005 and 2011 is estimated at 389 138 of which 26.5% of episodes were related to CVD (n = 103 118). CVD was responsible for a growing proportion of post-transplant hospitalizations over time (24.4%-30.4%, P < 0.001). Compared with nontransplant hospitals, transplant hospitals had similar length of stay (median length of stay, 3.7 days), higher median costs per hospitalization (US $10 364 vs US $8606, overall US $9324), and lower adjusted mortality (3.2% vs 3.9%, overall 3.6%; P = 0.003). Conclusions Inpatient CVD care is increasing over time for kidney transplant patients, accounting for 30% of all post-transplant hospitalizations. Variation exists in the inpatient care, outcomes, and costs between by hospital type. Further studies are needed to better understand the mechanisms behind these phenomena.
Shaping the Evolution of the Information Flow: The Centralizing Mechanisms in the Evolution of the North American Tobacco Quitline Consortium
Provan, Keith G., Mercken, Liesbeth , Leischow, Scott J. , Lemaire, Robin Hargroder

International Public Management Journal | January 17, 2017 | Volume: 20 | Issue: 3 | Pages: 467-488

10.1080/10967494.2016.1276034 | PMID 30880902 Get It

Electromyographic analysis of gluteus maximus and hamstring activity during the supine resisted hip extension exercise versus supine unilateral bridge to neutral
Youdas, James W., Hartman, James P., Murphy, Brooke A., Rundle, Ashley M., Ugorowski, Jenna M., Hollman, John H. , Hollman, John

Physiotherapy Theory and Practice | January 17, 2017 | Volume: 33 | Issue: 2 | Pages: 124-130

10.1080/09593985.2016.1271848 | PMID 28095102 Get It

Spectrum of Xanthogranulomatous Processes in the Abdomen and Pelvis: A Pictorial Review of Infectious, Inflammatory, and Proliferative Responses
Bourm, Kelsey S. , Menias, Christine O. , Ali, Kamran , Alhalabi, Kinan , Elsayes, Khaled M.

American Journal of Roentgenology | January 17, 2017 | Volume: 208 | Issue: 3 | Pages: 475-484

10.2214/ajr.16.17075 | PMID 28095017 Get It

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management
Gertz, Morie A.

American Journal of Hematology | January 17, 2017 | Volume: 92 | Issue: 2 | Pages: 209-217

10.1002/ajh.24557 | PMID 28094456 Get It

Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and rarely hyperviscosity.Diagnosis: Presence of IgM monoclonal protein associated with ≥10% clonal lymphoplasmacytic cells in bone marrow confirms the diagnosis. The L265P mutation in MYD88 is detectable in more than 90% of patients.Risk Stratification: Age, hemoglobin level, platelet count, β2 microglobulin, and monoclonal IgM concentrations are characteristics required for prognosis.Risk‐Adapted Therapy: Not all patients who fulfill WM criteria require therapy; these patients can be observed until symptoms develop. Rituximab‐based therapy is used in virtually all U.S. patients with WM and can be combined with bendamustine, an alkylating agent, or a proteosome inhibitor. Purine nucleoside analogues are widely used in Europe. The preferred Mayo Clinic nonstudy therapeutic induction is rituximab and bendamustine. Potential for stem cell transplantation should be considered in induction therapy selection.Management of Refractory Disease: Bortezomib, fludarabine, thalidomide, everolimus, ibrutinib, carfilzomib, lenalidomide, and bendamustine have all been shown to have activity in WM. Given WM's natural history, reduction of complications will be a priority for future treatment trials. Am. J. Hematol. 92:209–217, 2017. © 2016 Wiley Periodicals, Inc.
Faculty Opinions recommendation of CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells.
Maher, Jim

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 17, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727114789.793527227 Get It

FOVEAL EXUDATE AND CHOROIDAL NEOVASCULARIZATION IN ATYPICAL CASES OF MULTIPLE EVANESCENT WHITE DOT SYNDROME
Chen, Kevin C. , Marsiglia, Marcela, Dolz‐Marco, Rosa , Zahid, Sarwar, Mrejen, Sarah , Pulido, José S. , Cohen, Salomon Y. , Freilich, Benjamin D, Yannuzzi, Lawrence A. , Freund, K. Bailey

Retina | January 17, 2017 | Volume: 37 | Issue: 11 | Pages: 2025-2034

10.1097/iae.0000000000001486 | PMID 28098736 Get It

Purpose: To describe atypical cases of multiple evanescent white dot syndrome (MEWDS) associated with foveal exudation, increased choroidal thickness, and secondary Type 2 (subretinal) neovascularization. Methods: Four cases of atypical MEWDS were studied at a retina referral center. Patients underwent evaluation with multimodal retinal imaging, including fluorescein angiography, indocyanine green angiography, spectral-domain and enhanced depth imaging optical coherence tomography (OCT). Two patients were imaged with OCT angiography. Results: Four patients (3 female, 1 male) with a median age of 23.5 years presented with acute onset, painless, decreased central vision. All cases demonstrated fundus findings consistent with MEWDS on color photography, indocyanine green angiography, fluorescein angiography, fundus autofluorescence, and structural OCT imaging. On structural OCT, all 4 patients were noted to have hyperreflective subretinal material and increased subfoveal choroidal thickness ranging from 307 μm to 515 μm. Type 2 neovascularization was diagnosed in all four patients using fluorescein angiography, indocyanine green angiography, and/or OCT angiography. Two patients had poor visual acuity at the last follow-up despite resolution of characteristic clinical findings of MEWDS. Conclusion: A subset of patients with atypical MEWDS may develop persistent poor vision due to subfoveal exudation and secondary Type 2 neovascularization. Patients showing increased choroidal thickness at presentation may be more susceptible to this unusual presentation.